Shiqiang Lu Ph.D.

Mr. Shiqiang Lu joined InxMed in June 2021 and has served as Senior Director, Antibody Discovery. He has more than 10 years of work experience in the field of antibody discovery and antibody optimization technology. He worked in Simcere from 2017 to 2021, in charge of the antibody discovery at its headquarters. From 2015 to 2017, he worked in GenScript as a senior scientist and was responsible for antibody discovery. Prior to that he worked as a doctor at the Jiangsu Provincial Hospital of Traditional Chinese Medicine. Dr. Lu holds a Ph.D. at the University of Hong Kong and graduated from Nanjing Medical University with a master’s degree.

Mr. Shiqiang Lu joined InxMed in June 2021 and has served as Senior Director, antibody discovery. He has more than 10 years of work experience in the field of antibody discovery and antibody optimization technology.

He worked in Simcere from 2017 to 2021, in charge of the antibody discovery at its headquarters. From 2015 to 2017, he worked in GenScript as a senior scientist and was responsible for antibody discovery. Prior to that he worked as a doctor at the Jiangsu Provincial Hospital of Traditional Chinese Medicine. Dr. Lu holds a Ph.D. at the University of Hong Kong and graduated from Nanjing Medical University with a master’s degree.